<VariationArchive VariationID="850219" VariationName="NM_001165963.4(SCN1A):c.238dup (p.Leu80fs)" VariationType="Duplication" Accession="VCV000850219" Version="8" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-02-20" DateCreated="2020-04-15" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="850603" VariationID="850219">
      <GeneList>
        <Gene Symbol="SCN1A" FullName="sodium voltage-gated channel alpha subunit 1" GeneID="6323" HGNC_ID="HGNC:10585" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="165984641" stop="166149161" display_start="165984641" display_stop="166149161" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="166845669" stop="167005641" display_start="166845669" display_stop="167005641" Strand="-" />
          </Location>
          <OMIM>182389</OMIM>
          <Haploinsufficiency last_evaluated="2012-07-06" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SCN1A">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2012-07-06" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SCN1A">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001165963.4(SCN1A):c.238dup (p.Leu80fs)</Name>
      <CanonicalSPDI>NC_000002.12:166073383:GG:GGG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>2q24.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="166073383" stop="166073384" display_start="166073383" display_stop="166073384" variantLength="1" positionVCF="166073383" referenceAlleleVCF="A" alternateAlleleVCF="AG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="166929893" stop="166929894" display_start="166929893" display_stop="166929894" variantLength="1" positionVCF="166929893" referenceAlleleVCF="A" alternateAlleleVCF="AG" />
      </Location>
      <ProteinChange>L80fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_8" sequenceAccession="LRG_8">
            <Expression>LRG_8:g.5256dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.166929895dup" Assembly="GRCh37">
            <Expression>NC_000002.11:g.166929895dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.166073385dup" Assembly="GRCh38">
            <Expression>NC_000002.12:g.166073385dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011906.1" sequenceAccession="NG_011906" sequenceVersion="1" change="g.5256dup">
            <Expression>NG_011906.1:g.5256dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001165963.4" sequenceAccession="NM_001165963" sequenceVersion="4" change="c.238dup" MANESelect="true">
            <Expression>NM_001165963.4:c.238dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001159435.1" sequenceAccession="NP_001159435" sequenceVersion="1" change="p.Leu80fs">
            <Expression>NP_001159435.1:p.Leu80fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001165964.3" sequenceAccession="NM_001165964" sequenceVersion="3" change="c.238dup">
            <Expression>NM_001165964.3:c.238dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001159436.1" sequenceAccession="NP_001159436" sequenceVersion="1" change="p.Leu80fs">
            <Expression>NP_001159436.1:p.Leu80fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001202435.3" sequenceAccession="NM_001202435" sequenceVersion="3" change="c.238dup">
            <Expression>NM_001202435.3:c.238dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001189364.1" sequenceAccession="NP_001189364" sequenceVersion="1" change="p.Leu80fs">
            <Expression>NP_001189364.1:p.Leu80fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001353948.2" sequenceAccession="NM_001353948" sequenceVersion="2" change="c.238dup">
            <Expression>NM_001353948.2:c.238dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001340877.1" sequenceAccession="NP_001340877" sequenceVersion="1" change="p.Leu80fs">
            <Expression>NP_001340877.1:p.Leu80fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001353949.2" sequenceAccession="NM_001353949" sequenceVersion="2" change="c.238dup">
            <Expression>NM_001353949.2:c.238dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001340878.1" sequenceAccession="NP_001340878" sequenceVersion="1" change="p.Leu80fs">
            <Expression>NP_001340878.1:p.Leu80fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001353950.2" sequenceAccession="NM_001353950" sequenceVersion="2" change="c.238dup">
            <Expression>NM_001353950.2:c.238dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001340879.1" sequenceAccession="NP_001340879" sequenceVersion="1" change="p.Leu80fs">
            <Expression>NP_001340879.1:p.Leu80fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001353951.2" sequenceAccession="NM_001353951" sequenceVersion="2" change="c.238dup">
            <Expression>NM_001353951.2:c.238dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001340880.1" sequenceAccession="NP_001340880" sequenceVersion="1" change="p.Leu80fs">
            <Expression>NP_001340880.1:p.Leu80fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001353952.2" sequenceAccession="NM_001353952" sequenceVersion="2" change="c.238dup">
            <Expression>NM_001353952.2:c.238dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001340881.1" sequenceAccession="NP_001340881" sequenceVersion="1" change="p.Leu80fs">
            <Expression>NP_001340881.1:p.Leu80fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001353954.2" sequenceAccession="NM_001353954" sequenceVersion="2" change="c.238dup">
            <Expression>NM_001353954.2:c.238dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001340883.1" sequenceAccession="NP_001340883" sequenceVersion="1" change="p.Leu80fs">
            <Expression>NP_001340883.1:p.Leu80fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001353955.2" sequenceAccession="NM_001353955" sequenceVersion="2" change="c.238dup">
            <Expression>NM_001353955.2:c.238dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001340884.1" sequenceAccession="NP_001340884" sequenceVersion="1" change="p.Leu80fs">
            <Expression>NP_001340884.1:p.Leu80fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001353957.2" sequenceAccession="NM_001353957" sequenceVersion="2" change="c.238dup">
            <Expression>NM_001353957.2:c.238dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001340886.1" sequenceAccession="NP_001340886" sequenceVersion="1" change="p.Leu80fs">
            <Expression>NP_001340886.1:p.Leu80fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001353958.2" sequenceAccession="NM_001353958" sequenceVersion="2" change="c.238dup">
            <Expression>NM_001353958.2:c.238dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001340887.1" sequenceAccession="NP_001340887" sequenceVersion="1" change="p.Leu80fs">
            <Expression>NP_001340887.1:p.Leu80fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001353960.2" sequenceAccession="NM_001353960" sequenceVersion="2" change="c.238dup">
            <Expression>NM_001353960.2:c.238dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001340889.1" sequenceAccession="NP_001340889" sequenceVersion="1" change="p.Leu80fs">
            <Expression>NP_001340889.1:p.Leu80fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001353961.2" sequenceAccession="NM_001353961" sequenceVersion="2" change="c.-2188dup">
            <Expression>NM_001353961.2:c.-2188dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006920.6" sequenceAccession="NM_006920" sequenceVersion="6" change="c.238dup">
            <Expression>NM_006920.6:c.238dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_008851.3" sequenceAccession="NP_008851" sequenceVersion="3" change="p.Leu80fs">
            <Expression>NP_008851.3:p.Leu80fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_148667.2" sequenceAccession="NR_148667" sequenceVersion="2" change="n.624dup">
            <Expression>NR_148667.2:n.624dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1684663586" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001165963.4(SCN1A):c.238dup (p.Leu80fs) AND Early infantile epileptic encephalopathy with suppression bursts" Accession="RCV001054342" Version="7">
        <ClassifiedConditionList TraitSetID="21987">
          <ClassifiedCondition DB="MedGen" ID="C0393706">Early infantile epileptic encephalopathy with suppression bursts</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-12-27" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001165963.4(SCN1A):c.238dup (p.Leu80fs) AND multiple conditions" Accession="RCV003483768" Version="1">
        <ClassifiedConditionList TraitSetID="68206">
          <ClassifiedCondition DB="MedGen" ID="C1852577">Febrile seizures, familial, 1</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1858673">Generalized epilepsy with febrile seizures plus, type 2</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1864987">Migraine, familial hemiplegic, 3</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0751122">Severe myoclonic epilepsy in infancy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no classification provided</ReviewStatus>
            <Description SubmissionCount="1">not provided</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-12-27" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2020-04-15" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">17347258</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18930999</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="68206" Type="TraitChoice" ContributesToAggregateClassification="false">
            <Trait ID="2953" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Migraine, familial hemiplegic, 3</ElementValue>
                <XRef ID="MONDO:0012320" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">FHM3</ElementValue>
                <XRef Type="MIM" ID="609634" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Familial hemiplegic migraine (FHM) falls within the category of migraine with aura. In migraine with aura (including FHM) the neurologic symptoms of aura are unequivocally localizable to the cerebral cortex or brain stem and include visual disturbance (most common), sensory loss (e.g., numbness or paresthesias of the face or an extremity), and dysphasia (difficulty with speech). FHM must include motor involvement, such as hemiparesis (weakness of an extremity). Hemiparesis occurs with at least one other symptom during FHM aura. Neurologic deficits with FHM attacks can be prolonged for hours to days and may outlast the associated migrainous headache. FHM is often earlier in onset than typical migraine, frequently beginning in the first or second decade; the frequency of attacks tends to decrease with age. Approximately 40%-50% of families with CACNA1A-FHM have cerebellar signs ranging from nystagmus to progressive, usually late-onset mild ataxia.</Attribute>
                <XRef ID="NBK1388" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10974" />
                <XRef ID="10974" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301562</ID>
                <ID Source="BookShelf">NBK1388</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="Orphanet, 2013">
                <URL>https://www.orpha.net/data/patho/Pro/en/Emergency_HemiplegicMigraine-enPro1031.pdf</URL>
                <CitationText>Orphanet, Hemiplegic Migraine (HM), 2013</CitationText>
              </Citation>
              <XRef ID="569" DB="Orphanet" />
              <XRef ID="C1864987" DB="MedGen" />
              <XRef ID="MONDO:0012320" DB="MONDO" />
              <XRef Type="MIM" ID="609634" DB="OMIM" />
            </Trait>
            <Trait ID="4140" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Epilepsy, Myoclonic, Infantile, Severe</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Epileptic encephalopathy, early infantile, 6 (Dravet syndrome)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Severe myoclonic epilepsy in infancy</ElementValue>
                <XRef ID="219513" DB="GeneTests" />
                <XRef ID="Dravet+Syndrome/2332" DB="Genetic Alliance" />
                <XRef ID="230437002" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 6A</ElementValue>
                <XRef Type="MIM" ID="607208" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Dravet syndrome</ElementValue>
                <XRef ID="MONDO:0100135" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">DEE6A</ElementValue>
                <XRef Type="MIM" ID="607208" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">EIEE6</ElementValue>
                <XRef Type="MIM" ID="607208" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">ICE-GTC</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">DRVT</ElementValue>
                <XRef Type="MIM" ID="607208" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">SMEI</ElementValue>
                <XRef Type="MIM" ID="607208" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">SME</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">SCN1A seizure disorders encompass a spectrum that ranges from simple febrile seizures and generalized epilepsy with febrile seizures plus (GEFS+) at the mild end to Dravet syndrome and intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC) at the severe end. Phenotypes with intractable seizures including Dravet syndrome are often associated with cognitive decline. Less commonly observed phenotypes include myoclonic astatic epilepsy (MAE), Lennox-Gastaut syndrome, infantile spasms, epilepsy with focal seizures, and vaccine-related encephalopathy and seizures. The phenotype of SCN1A seizure disorders can vary even within the same family.</Attribute>
                <XRef ID="NBK1318" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301494</ID>
                <ID Source="BookShelf">NBK1318</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="Orphanet, 2008">
                <URL>https://www.orpha.net/data/patho/Pro/en/Emergency_Dravet.pdf</URL>
                <CitationText>Orphanet, Dravet syndrome, 2008</CitationText>
              </Citation>
              <Citation Type="general" Abbrev="EFNS, 2010">
                <ID Source="PubMed">20298421</ID>
              </Citation>
              <Citation Type="Suggested Reading">
                <ID Source="PubMed">28880996</ID>
              </Citation>
              <XRef ID="33069" DB="Orphanet" />
              <XRef ID="C0751122" DB="MedGen" />
              <XRef ID="MONDO:0100135" DB="MONDO" />
              <XRef Type="MIM" ID="607208" DB="OMIM" />
            </Trait>
            <Trait ID="5142" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">FEB1</ElementValue>
                <XRef ID="MONDO:0007367" DB="MONDO" />
                <XRef Type="MIM" ID="121210" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Febrile seizures, familial, 1</ElementValue>
                <XRef ID="MONDO:0007367" DB="MONDO" />
              </Name>
              <XRef ID="C1852577" DB="MedGen" />
              <XRef ID="MONDO:0007367" DB="MONDO" />
              <XRef Type="MIM" ID="121210" DB="OMIM" />
            </Trait>
            <Trait ID="9389" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">GEFS+, TYPE 2</ElementValue>
                <XRef Type="MIM" ID="604403" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Generalized epilepsy with febrile seizures plus, type 2</ElementValue>
                <XRef ID="Generalized+epilepsy+with+febrile+seizures+plus%2C+type+2/8460" DB="Genetic Alliance" />
                <XRef ID="MONDO:0011461" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">GEFSP2</ElementValue>
                <XRef Type="MIM" ID="604403" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">GEFS+2</ElementValue>
                <XRef Type="MIM" ID="604403" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18661" />
                <XRef ID="18661" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">SCN1A seizure disorders encompass a spectrum that ranges from simple febrile seizures and generalized epilepsy with febrile seizures plus (GEFS+) at the mild end to Dravet syndrome and intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC) at the severe end. Phenotypes with intractable seizures including Dravet syndrome are often associated with cognitive decline. Less commonly observed phenotypes include myoclonic astatic epilepsy (MAE), Lennox-Gastaut syndrome, infantile spasms, epilepsy with focal seizures, and vaccine-related encephalopathy and seizures. The phenotype of SCN1A seizure disorders can vary even within the same family.</Attribute>
                <XRef ID="NBK1318" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">SCN1A-Related Seizure Disorders</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301494</ID>
                <ID Source="BookShelf">NBK1318</ID>
              </Citation>
              <XRef ID="36387" DB="Orphanet" />
              <XRef ID="C1858673" DB="MedGen" />
              <XRef ID="MONDO:0011461" DB="MONDO" />
              <XRef Type="MIM" ID="604403" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="21987" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="32998" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Developmental and epileptic encephalopathy</ElementValue>
                <XRef ID="MONDO:0100062" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Early infantile epileptic encephalopathy</ElementValue>
                <XRef ID="1934" DB="Orphanet" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ohtahara syndrome</ElementValue>
                <XRef ID="1934" DB="Orphanet" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Early infantile epileptic encephalopathy with suppression bursts</ElementValue>
                <XRef ID="230429005" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">EIEE</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9255" />
                <XRef ID="9255" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="1934" DB="Orphanet" />
              <XRef ID="C0393706" DB="MedGen" />
              <XRef ID="MONDO:0100062" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS308350" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7901652" SubmissionDate="2023-12-29" DateLastUpdated="2024-01-26" DateCreated="2024-01-26">
        <ClinVarSubmissionID localKey="nvtapin_pin_20614" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004228666" DateUpdated="2024-01-26" DateCreated="2024-01-26" Type="SCV" Version="1" SubmitterName="GenomeConnect - Invitae Patient Insights Network" OrgID="508034" OrganizationCategory="patient registry" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
          <Comment>Variant interpreted as Pathogenic and reported on 01-04-2020 by Lab Invitae. GenomeConnect-Invitae Patient Insights Network assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. Registry team members make no attempt to reinterpret the clinical significance of the variant. Phenotypic details are available under supporting information.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">0</Age>
              <Age Type="maximum" age_unit="years">9</Age>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
              <Gender>female</Gender>
              <Indication Type="Indication">
                <Trait Type="Finding">
                  <Name>
                    <ElementValue Type="Preferred">Diagnostic</ElementValue>
                  </Name>
                </Trait>
              </Indication>
            </Sample>
            <Method>
              <Description>Gene Panel Sequencing</Description>
              <MethodType>phenotyping only</MethodType>
              <ObsMethodAttribute>
                <Attribute Type="TestingLaboratory" dateValue="2020-01-04" integerValue="500031">Invitae</Attribute>
                <Comment>Pathogenic</Comment>
              </ObsMethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
            <TraitSet DateLastEvaluated="2022-02-03" Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001250" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SCN1A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001165963.1:c.238dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1852577" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1858673" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0751122" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1864987" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14120880</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2384089" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2020-04-15">
        <ClinVarSubmissionID localKey="9135341|MedGen:C0393706" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001218651" DateUpdated="2024-02-20" DateCreated="2020-04-15" Type="SCV" Version="6" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-12-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">17347258</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18930999</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in SCN1A are known to be pathogenic (PMID: 17347258, 18930999). This variant has not been reported in the literature in individuals with SCN1A-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Leu80Profs*8) in the SCN1A gene. It is expected to result in an absent or disrupted protein product.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SCN1A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000002.11:g.166929893_166929894insG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0393706" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12699154</SubmissionName>
          <SubmissionName>SUB14200314</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7901652" TraitType="Disease" MappingType="XRef" MappingValue="C0751122" MappingRef="MedGen">
        <MedGen CUI="C0751122" Name="Severe myoclonic epilepsy in infancy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7901652" TraitType="Disease" MappingType="XRef" MappingValue="C1858673" MappingRef="MedGen">
        <MedGen CUI="C1858673" Name="Generalized epilepsy with febrile seizures plus, type 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7901652" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001250" MappingRef="HP">
        <MedGen CUI="C0036572" Name="Seizure" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2384089" TraitType="Disease" MappingType="XRef" MappingValue="C0393706" MappingRef="MedGen">
        <MedGen CUI="C0393706" Name="Early infantile epileptic encephalopathy with suppression bursts" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7901652" TraitType="Disease" MappingType="XRef" MappingValue="C1864987" MappingRef="MedGen">
        <MedGen CUI="C1864987" Name="Migraine, familial hemiplegic, 3" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7901652" TraitType="Disease" MappingType="XRef" MappingValue="C1852577" MappingRef="MedGen">
        <MedGen CUI="C1852577" Name="Febrile seizures, familial, 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

